{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Law and Legislation", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "3", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/02/upshot/speedy-drug-approvals-have-become-the-rule-not-the-exception.html", "document_type": "article", "byline": {"person": [{"lastname": "SANGER-KATZ", "firstname": "Margot", "role": "reported", "organization": "", "rank": 1}], "original": "By MARGOT SANGER-KATZ"}, "type_of_material": "News", "multimedia": [{"url": "images/2015/05/01/upshot/02up-drugs2-1430447924094/02up-drugs2-1430447924094-thumbWide.png", "legacy": {"wide": "images/2015/05/01/upshot/02up-drugs2-1430447924094/02up-drugs2-1430447924094-thumbWide.png", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2015/05/01/upshot/02up-drugs2-1430447924094/02up-drugs2-1430447924094-articleLarge.png", "legacy": {"xlarge": "images/2015/05/01/upshot/02up-drugs2-1430447924094/02up-drugs2-1430447924094-articleLarge.png", "xlargeheight": "462", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 462}, {"url": "images/2015/05/01/upshot/02up-drugs2-1430447924094/02up-drugs2-1430447924094-thumbStandard.png", "legacy": {"thumbnail": "images/2015/05/01/upshot/02up-drugs2-1430447924094/02up-drugs2-1430447924094-thumbStandard.png", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "The Upshot", "word_count": "796", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Most recent drug development in the U.S. has been done through specially approved pathways, and two more may be added.", "pub_date": "2015-05-02T00:00:00Z", "news_desk": "Upshot", "headline": {"kicker": "The Upshot", "main": "Speedy Drug Approvals Have Become the Rule, Not the Exception  ", "content_kicker": "Public Health"}, "print_page": null, "snippet": "Most recent drug development in the U.S. has been done through specially approved pathways, and two more may be added.", "_id": "5543409938f0d83d46e51fee", "slideshow_credits": null, "abstract": null}